Science Corporation has implanted its Prima chip in a patient with Stargardt disease, marking a step toward restoring vision for those with incurable retinal conditions.
Neuralink has leveraged 50,000 hours of brain signal data to enhance its brain-computer interface, achieving record-breaking cursor control speeds and significantly reducing calibration time.
Neuralink has demonstrated a new capability for its brain-computer interface, allowing a patient with speech impairment to communicate using synthesized voice output.
Neuralink has showcased its N1 brain implant successfully converting imagined speech into synthesized words for a patient with amyotrophic lateral sclerosis.
Neuralink co-founder Max Hodak will discuss the future of brain-computer interfaces at TechCrunch Disrupt 2026, following his company's $1.5 billion valuation.
